One of the more controversial aspects of the 21st Century Cures bill -- a bill aimed at fast-tracking drug development that just passed the House Energy and Commerce Committee last week -- was a section that didn't end up in the bill.
One of the more controversial aspects of the 21st Century Cures bill -- a bill aimed at fast-tracking drug development that just passed the House Energy and Commerce Committee last week -- was a section that didn't end up in the bill.